This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV

This study has been completed.
Sponsor:
Collaborator:
University of Osnabrueck
Information provided by (Responsible Party):
Klaus Kenn, Klinikum Berchtesgadener Land der Schön-Kliniken
ClinicalTrials.gov Identifier:
NCT01478646
First received: September 30, 2011
Last updated: November 22, 2011
Last verified: November 2011
September 30, 2011
November 22, 2011
August 2011
November 2011   (Final data collection date for primary outcome measure)
Change in BORG-Scale [ Time Frame: Change from pre (minute o) in BORG-scale at directly post intervention (minute 60) ]
Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea).
Same as current
No Changes Posted
Change in residual volume [ Time Frame: change from pre (minute 0) in residual volume at post (minute 60) intervention ]
measured by a portable spirometry device
Same as current
Not Provided
Not Provided
 
The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV
The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea and Activity in Patients With COPD III-IV
The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea and increase activity.

In the treatment of COPD-Patients different kinds of breathing therapy techniques are used, but many of them are not reassessed yet.

Dyspnea is one of the predominant symptoms of COPD patients and has negative impacts on the activity of the patients. Dyspnea during exertion leads to avoiding activity and results in a deconditioning of muscles and of the cardiovascular system.

Thus breathing therapy techniques seem to be useful, which may lead to a decrease of dyspnea and an increase of activity.

The purpose of this study is to determine whether reflective breathing therapy is more effective on decreasing dyspnea and increasing activity than conventional breathing therapy.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Chronic Obstructive Pulmonary Disease
  • Other: conventional breathing therapy
    duration: 60 minutes.
  • Other: reflectory breathing therapy
    duration: 60 minutes.
  • Experimental: Conventional breathing therapy
    first: conventional breathing therapy, second: reflectory breathing therapy
    Intervention: Other: conventional breathing therapy
  • Experimental: Reflectory breathing therapy
    first: reflectory breathing therapy second: conventional breathing therapy
    Intervention: Other: reflectory breathing therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
November 2011
November 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • inpatient rehabilitation
  • COPD (Gold stage III and IV)

Exclusion Criteria:

  • severe exacerbation in the last four weeks
  • acute infections
  • fever
  • neuritides
  • severe osteoporosis
  • skin disease
  • manic depression
Sexes Eligible for Study: All
45 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT01478646
RAT 2011
KBerchtesgadener ( Registry Identifier: KBerchtesgadener )
No
Not Provided
Not Provided
Not Provided
Klaus Kenn, Klinikum Berchtesgadener Land der Schön-Kliniken
Klinikum Berchtesgadener Land der Schön-Kliniken
University of Osnabrueck
Study Chair: Klaus Kenn, Dr. med. Schön Klinik Berchtesgadener Land
Principal Investigator: Stella Seeberg University of Osnabrueck
Klinikum Berchtesgadener Land der Schön-Kliniken
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP